Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Freeman

Showing results (821-830 of 863) with videos related to

Pageof 87
Sort By:
Developmental Medicine and Child Neurology|February 3, 2009
Coprophenomena in Tourette syndromeRoger D Freeman, Samuel H Zinner, Kirsten R Müller-Vahl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2023
Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine LengthCourtney K Walker, Kelsey M Greathouse, Jennifer J Tuscher, et al.
Blood|August 6, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AMLJad Othman, Nicola Potter, Sylvie D Freeman, et al.
Blood Advances|May 12, 2023
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trialJad Othman, Charlotte Wilhelm-Benartzi, Richard Dillon, et al.
Annals of Vascular Surgery|December 29, 2020
Higher Risk for Reintervention in Patients after Stenting for Radiation-Induced Internal Carotid Artery Stenosis: A Single-Center Analysis and Systematic ReviewYoung Erben, Camila Franco-Mesa, David Miller, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
Safety and Feasibility of a Fast-Track Pathway for Neurosurgical Craniotomy Patients: Bypassing the Intensive Care UnitCarlos Perez-Vega, Devang K Sanghavi, Pablo Moreno Franco, et al.
Cancer|June 27, 2025
Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment ConsortiumMichael Boyiadzis, Andrew H Wei, Bruno Paiva, et al.
The Lancet. Haematology|April 30, 2025
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trialsNicola Potter, Jelena Jovanovic, Adam Ivey, et al.
Neurology|November 11, 2018
<i>PCNT</i> point mutations and familial intracranial aneurysmsOswaldo Lorenzo-Betancor, Patrick R Blackburn, Emily Edwards, et al.
Disaster Medicine and Public Health Preparedness|January 14, 2022
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency UseAnastasia S Lambrou, John T Redd, Miles A Stewart, et al.
Pageof 87

Showing results (821-830 of 863) with videos related to

Sort By:
Pageof 87
Developmental Medicine and Child Neurology|February 3, 2009
Coprophenomena in Tourette syndromeRoger D Freeman, Samuel H Zinner, Kirsten R Müller-Vahl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2023
Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine LengthCourtney K Walker, Kelsey M Greathouse, Jennifer J Tuscher, et al.
Blood|August 6, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AMLJad Othman, Nicola Potter, Sylvie D Freeman, et al.
Blood Advances|May 12, 2023
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trialJad Othman, Charlotte Wilhelm-Benartzi, Richard Dillon, et al.
Annals of Vascular Surgery|December 29, 2020
Higher Risk for Reintervention in Patients after Stenting for Radiation-Induced Internal Carotid Artery Stenosis: A Single-Center Analysis and Systematic ReviewYoung Erben, Camila Franco-Mesa, David Miller, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
Safety and Feasibility of a Fast-Track Pathway for Neurosurgical Craniotomy Patients: Bypassing the Intensive Care UnitCarlos Perez-Vega, Devang K Sanghavi, Pablo Moreno Franco, et al.
Cancer|June 27, 2025
Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment ConsortiumMichael Boyiadzis, Andrew H Wei, Bruno Paiva, et al.
The Lancet. Haematology|April 30, 2025
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trialsNicola Potter, Jelena Jovanovic, Adam Ivey, et al.
Neurology|November 11, 2018
<i>PCNT</i> point mutations and familial intracranial aneurysmsOswaldo Lorenzo-Betancor, Patrick R Blackburn, Emily Edwards, et al.
Disaster Medicine and Public Health Preparedness|January 14, 2022
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency UseAnastasia S Lambrou, John T Redd, Miles A Stewart, et al.
Pageof 87